Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03991832
Title Study of Olaparib and Durvalumab in IDH-Mutated Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University Health Network, Toronto
Indications

oligodendroglioma

Advanced Solid Tumor

biliary tract cancer

adult astrocytic tumour

Therapies

Durvalumab + Olaparib

Age Groups: adult | senior
Covered Countries CAN

Additional content available in CKB BOOST